More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review

Lawrence D Hayes, Joanne Ingram, Nicholas F Sculthorpe, Lawrence D Hayes, Joanne Ingram, Nicholas F Sculthorpe

Abstract

Background: Persistent coronavirus disease 2019 (COVID-19) symptoms are increasingly well-reported in cohort studies and case series. Given the spread of the pandemic, number of individuals suffering from persistent symptoms, termed 'long COVID', are significant. However, type and prevalence of symptoms are not well reported using systematic literature reviews. Objectives: In this scoping review of the literature, we aggregated type and prevalence of symptoms in people with long COVID. Eligibility Criteria: Original investigations concerning the name and prevalence of symptoms were considered in participants ≥4-weeks post-infection. Sources of Evidence: Four electronic databases [Medline, Web of Science, Scopus, and the Cochrane Central Register of Controlled Trials (CENTRAL)] were searched. Methods: A scoping review was conducted using the Arksey and O'Malley framework. Review selection and characterisation was performed by three independent reviewers using pretested forms. Results: Authors reviewed 2,711 titles and abstracts for inclusion with 152 selected for full-text review. 102 articles were subsequently removed as this did not meet inclusion criteria. Thus, fifty studies were analysed, 34 of which were described as cohort studies or prospective cohort studies, 14 were described as cross-sectional studies, one was described as a case control study, and one was described as a retrospective observational study. In total, >100 symptoms were identified and there was considerable heterogeneity in symptom prevalence and setting of study. Ten studies reported cardiovascular symptoms, four examined pulmonary symptoms, 25 reported respiratory symptoms, 24 reported pain-related symptoms, 21 reported fatigue, 16 reported general infection symptoms, 10 reported symptoms of psychological disorders, nine reported cognitive impairment, 31 reported a sensory impairment, seven reported a dermatological complaint, 11 reported a functional impairment, and 18 reported a symptom which did not fit into any of the above categories. Conclusion: Most studies report symptoms analogous to those apparent in acute COVID-19 infection (i.e., sensory impairment and respiratory symptoms). Yet, our data suggest a larger spectrum of symptoms, evidenced by >100 reported symptoms. Symptom prevalence varied significantly and was not explained by data collection approaches, study design or other methodological approaches, and may be related to unknown cohort-specific factors.

Keywords: COVID-19; SARS-CoV-2; coronavirus–COVID-19; long COVID; persistent; post acute covid syndrome (PACS); symptoms.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Hayes, Ingram and Sculthorpe.

Figures

Figure 1
Figure 1
Schematic flow diagram describing exclusions of potential studies and final number of studies.

References

    1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. (2020) 324:782–93. 10.1001/jama.2020.12839
    1. Coronavirus (COVID-19) events as they happen . Available online at: (accessed June 10, 2021).
    1. De Lorenzo R, Conte C, Lanzani C, Benedetti F, Roveri L, Mazza MG, et al. . Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study. PLoS ONE. (2020) 15:e0239570. 10.1371/journal.pone.0239570
    1. Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. (2020) 12:135. 10.3390/v12020135
    1. Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. . (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. (2021) 1–11. 10.1007/s00259-021-05215-4
    1. Overview . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19 Guidance NICE. Available online at at: (accessed September 14, 2021).
    1. V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. (2020) 19:155–70. 10.1038/s41579-020-00468-6
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. (2020) 323:1239–42. 10.1001/jama.2020.2648
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727–33. 10.1056/NEJMoa2001017
    1. Why we need to keep using the patient made term “Long Covid ” . The BMJ. (2020). Available online at: (accessed September 20, 2021).
    1. Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, et al. . Long-COVID: An evolving problem with an extensive impact. Samj South Afr Med J. (2021) 111:10–2. 10.7196/SAMJ.2020.v111i11.15433
    1. Kingstone T, Taylor AK, O'Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the “right” GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. (2020) 4:bjgpopen20X101143. 10.3399/bjgpopen20X101143
    1. Alwan NA. A negative COVID-19 test does not mean recovery. Nature. (2020) 584:170. 10.1038/d41586-020-02335-z
    1. Tenforde MW. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:993–8. 10.15585/mmwr.mm6930e1
    1. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. (2021) 27:89–95. 10.1016/j.cmi.2020.09.023
    1. Machado FVC, Meys R, Delbressine JM, Vaes AW, Goërtz YMJ, van Herck M, et al. . Construct validity of the Post-COVID-19 functional status scale in adult subjects with COVID-19. Health Qual Life Outcomes. (2021) 19:40. 10.1186/s12955-021-01691-2
    1. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220–32. 10.1016/S0140-6736(20)32656-8
    1. Mannan A, Mehedi HMH, Chy NUHA, Qayum MO, Akter F, Rob MA, et al. . A multi-centre, cross-sectional study on coronavirus disease 2019 in Bangladesh: clinical epidemiology and short-term outcomes in recovered individuals. New Microbes New Infect. (2021) 40:100838. 10.1016/j.nmni.2021.100838
    1. Goertz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. . Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? Erj Open Research. (2020) 6. 10.1183/23120541.00542-2020
    1. Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. . Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. (2020) 15:e0243882. 10.1371/journal.pone.0243882
    1. Meys R, Delbressine JM, Goërtz YMJ, Vaes AW, Machado FVC, Van Herck M, et al. . Generic and respiratory-specific quality of life in non-hospitalized patients with COVID-19. J Clin Med. (2020) 9:3993. 10.3390/jcm9123993
    1. Tomasoni D, Bai F, Castoldi R, Barbanotti D, Falcinella C, Mulè G, et al. . Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy. J Med Virol. (2021) 93:1175–9. 10.1002/jmv.26459
    1. Trinkmann F, Müller M, Reif A, Kahn N, Kreuter M, Trudzinski F, et al. . Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. Eur Respir J. (2021) 57:2003002. 10.1183/13993003.03002-2020
    1. Carfì A, Bernabei R, Landi F. Gemelli Against COVID-9 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603. 10.1001/jama.2020.12603
    1. Taboada M, Moreno E, Cariñena A, Rey T, Pita-Romero R, Leal S, et al. . Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. (2020) 126:e110–3. 10.1016/j.bja.2020.12.007
    1. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. (2020) 15:e0240784. 10.1371/journal.pone.0240784
    1. Boscolo-Rizzo P, Borsetto D, Fabbris C, Spinato G, Frezza D, Menegaldo A, et al. . Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. (2020) 146:729–32. 10.1001/jamaoto.2020.1379
    1. Dennis A, Wamil M, Kapur S, Alberts J, Badley AD, Decker GA, et al. . Multi-organ impairment in low-risk individuals with long COVID. medRxiv. (2020) 2020.10.14.20212555. 10.1101/2020.10.14.20212555
    1. Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. . Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. (2021) 4:e2036142. 10.1001/jamanetworkopen.2020.36142
    1. Woo MS, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, et al. . Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. (2020) 2:fcaa205. 10.1093/braincomms/fcaa205
    1. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. (2020) 76:405–7. 10.1136/thoraxjnl-2020-216377
    1. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. . Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. (2020) 81:E4–6. 10.1016/j.jinf.2020.08.029
    1. van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. . Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. (2020) 73:e1089–98. 10.1093/cid/ciaa1750
    1. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. (2020) 2020.10.19.20214494. 10.1101/2020.10.19.20214494
    1. Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia. Acad Radiol. (2021) 28:28–35. 10.1016/j.acra.2020.10.006
    1. Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. (2021) 36:100899. 10.1016/j.eclinm.2021.100899
    1. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. (2021) 11:16144. 10.1038/s41598-021-95565-8
    1. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. (2005) 8:19–32. 10.1080/1364557032000119616
    1. Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. (2018) 18:143. 10.1186/s12874-018-0611-x
    1. Mays N, Roberts E, Popay J. Synthesising research evidence. In: Fulop N, Allen P, Clarke A, Black N, editors. Studying the Organisation and Delivery of Health Services: Research Methods. London: Routledge; (2001). p. 188–220.
    1. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. . PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. (2018) 169:467–73. 10.7326/M18-0850
    1. Cai X, Hu X, Ekumi IO, Wang J, An Y, Li Z, et al. . Psychological distress and its correlates among COVID-19 survivors during early convalescence across age groups. Am J Geriatr Psychiatry. (2020) 28:1030–9. 10.1016/j.jagp.2020.07.003
    1. Caronna E Ballvé A Llaurad ó A Gallardo VJ Ariton DM Lallana S et al. . Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. (2020) 40:1410–21. 10.1177/0333102420965157
    1. Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. (2020) 27:258–63. 10.1016/j.cmi.2020.09.052
    1. Chiesa-Estomba CM, Lechien JR, Radulesco T, Michel J, Sowerby LJ, Hopkins C, et al. . Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. (2020) 27:2318–21. 10.1111/ene.14440
    1. Curci C, Negrini F, Ferrillo M, Bergonzi R, Bonacci E, Camozzi DM, et al. . Functional outcome after inpatient rehabilitation in post-intensive care unit COVID-19 patients: findings and clinical implications from a real-practice retrospective study. Eur J Phys Rehabil Med. (2021) 57:443–50. 10.23736/S1973-9087.20.06660-5
    1. Fjaeldstad AW. Prolonged complaints of chemosensory loss after COVID-19. Dan Med J. (2020) 67:A05200340.
    1. Frija-Masson J, Debray M-P, Gilbert M, Lescure F-X, Travert F, Borie R, et al. . Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J. (2020) 56:2001754. 10.1183/13993003.01754-2020
    1. Galván-Tejada CE, Herrera-García CF, Godina-González S, Villagrana-Bañuelos KE, Amaro JDL, Herrera-García K, et al. . Persistence of covid-19 symptoms after recovery in mexican population. Int J Environ Res Public Health. (2020) 17:1–12. 10.3390/ijerph17249367
    1. Hall J, Myall K, Lam JL, Mason T, Mukherjee B, West A, et al. . Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. (2021) 76:408–11. 10.1136/thoraxjnl-2020-215861
    1. Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. . Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc Imaging. (2020) 13:2330–9. 10.1016/j.jcmg.2020.05.004
    1. Iannuzzi L, Salzo AE, Angarano G, Palmieri VO, Portincasa P, Saracino A, et al. . Gaining back what is lost: recovering the sense of smell in mild to moderate patients after COVID-19. Chem Senses. (2020) 45:875–81. 10.1093/chemse/bjaa066
    1. Janiri D, Kotzalidis GD, Giuseppin G, Molinaro M, Modica M, Montanari S, et al. . Psychological distress after Covid-19 recovery: reciprocal effects with temperament and emotional dysregulation. an exploratory study of patients over 60 years of age assessed in a post-acute care service. Front Psychiatry. (2020) 11:590135. 10.3389/fpsyt.2020.590135
    1. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. (2020) 75:e13746. 10.1111/ijcp.13746
    1. Konstantinidis I, Delides A, Tsakiropoulou E, Maragoudakis P, Sapounas S, Tsiodras S. Short-term follow-up of self-isolated COVID-19 patients with smell and taste dysfunction in greece: two phenotypes of recovery. ORL J Otorhinolaryngol Relat Spec. (2020) 82:295–303. 10.1159/000511436
    1. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. . “Long-COVID”: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. (2020) 76:396–98. 10.1136/thoraxjnl-2020-215818
    1. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. . Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. (2020) 89:594–600. 10.1016/j.bbi.2020.07.037
    1. Méndez R, Balanzá-Martínez V, Luperdi SC, Estrada I, Latorre A, González-Jiménez P, et al. . Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern Med. (2021) 290:621–31. 10.1111/joim.13262
    1. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al. . Post-acute COVID-19 syndrome. Incidence and risk factors: a mediterranean cohort study. J Infect. (2021) 82:378–83. 10.1016/j.jinf.2021.01.004
    1. Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases. Int J Audiol. (2020) 59:889–90. 10.1080/14992027.2020.1798519
    1. Niklassen AS, Draf J, Huart C, Hintschich C, Bocksberger S, Trecca EMC, et al. . COVID-19: recovery from chemosensory dysfunction. A multicentre study on smell and taste. Laryngoscope. (2021) 131:1095–100. 10.1002/lary.29383
    1. Ortelli P, Ferrazzoli D, Sebastianelli L, Engl M, Romanello R, Nardone R, et al. . Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. J Neurol Sci. (2021) 420:117271. 10.1016/j.jns.2020.117271
    1. Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME Á, Steig B, et al. . Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. (2020). 10.1093/cid/ciaa1792. [Epub ahead of print].
    1. Poncet-Megemont L, Paris P, Tronchere A, Salazard J-P, Pereira B, Dallel R, et al. . High prevalence of headaches during Covid-19 infection: a retrospective cohort study. Headache. (2020) 60:2578–82. 10.1111/head.13923
    1. Printza A, Katotomichelakis M, Metallidis S, Panagopoulos P, Sarafidou A, Petrakis V, et al. . The clinical course of smell and taste loss in COVID-19 hospitalized patients. Hippokratia. (2020) 24:66–71.
    1. Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. (2021) 31:100683. 10.1016/j.eclinm.2020.100683
    1. Shah AS, Wong AW, Hague CJ, Murphy DT, Johnston JC, Ryerson CJ, et al. . A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. (2020) 76:402–4. 10.1136/thoraxjnl-2020-216308
    1. Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. . Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur Respir J. (2020) 57:2003481. 10.1183/13993003.03481-2020
    1. Taboada M, Cariñena A, Moreno E, Rodríguez N, Domínguez MJ, Casal A, et al. . Post-COVID-19 functional status six-months after hospitalization. J Infect. (2020) 82:e31–3. 10.1016/j.jinf.2020.12.022
    1. Yan CH, Prajapati DP, Ritter ML, DeConde AS. Persistent Smell Loss Following Undetectable SARS-CoV-2. Otolaryngol Head Neck Surg. (2020) 163:923–5. 10.1177/0194599820934769
    1. Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, et al. . Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. (2020) 25:100463. 10.1016/j.eclinm.2020.100463
    1. Curci C, Pisano F, Bonacci E, Camozzi DM, Ceravolo C, Bergonzi R, et al. . Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol. Eur J Phys Rehabil Med. (2020) 56:633–41. 10.23736/S1973-9087.20.06339-X
    1. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021). 10.1016/j.eclinm.2021.101019. [Epub ahead of print].
    1. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. . Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. (2020) 34:101623. 10.1016/j.tmaid.2020.101623
    1. Vink M, Vink-Niese A. Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the qure study for Q-Fever fatigue syndrome. Health Care. (2020) 8:552. 10.3390/healthcare8040552
    1. Garner P. Paul garner: For 7 weeks I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion. BMJ. (2020). Available online at:
    1. Lokugamage AU, Taylor S, Rayner C. Patients' experiences of “longcovid” are missing from the NHS narrative. BMJ Opinion. (2020). Available online at:
    1. Baig AM. (2020). Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers. J Med Virol. 10.1002/jmv.26624
    1. Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. (2003) 20:54–60. 10.1136/emj.20.1.54
    1. Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. . Preliminary evidence on long COVID in children. Acta Paediatr. (2021) 110:2208–11. 10.1111/apa.15870
    1. Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. (2021) 110:914–21. 10.1111/apa.15673
    1. Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. . Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. (2021) 2101341. 10.1183/13993003.01341-2021
    1. Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Ital J Pediatr. (2021) 47:177. 10.1186/s13052-021-01127-z

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe